Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.